Active Recombinant Human ST14 Protein, Met & His-tagged

• Cat.No.: ST14-742H
• Product Overview: Recombinant Human ST14 (Accession # NP_068813) Gly596-Val855, fused with an N-terminal Met and 6-His tag, was produced in E. coli.

Specification

• Source: E. coli
• Species: Human
• Tag: & His
• Predicted N Terminal: Val615
• Form: Supplied as a 0.2 µm filtered solution in Tris-HCl and Glycerol.
• Bio-activity: Measured by its ability to cleave the fluorogenic peptide substrate Boc-QAR-AMC.The specific activity is >10,000 pmol/min/µg, as measured under the described conditions.
• Molecular Mass: Recombinant Human ST14, Met & His-tagged has a calculated MW of 26 kDa; Other fragments of 19 kDa, 17 kDa, 9 kDa and 6 kDa are also observed in the recombinant protein preparation.. In SDS-PAGE migrates as 27 kDa (major), 20 kDa, 17 kDa, 10 kDa, 6.5 kDa, reducing conditions.
• Protein length: Gly596-Val855
• Purity: >90%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• Storage: Avoid repeated freeze-thaw cycles. No activity loss was observed after storage at: In lyophilized state for 1 year (4ºC); After reconstitution under sterile conditions for 3 months (-70ºC).

Gene Information

• Gene Name: ST14 suppression of tumorigenicity 14 (colon carcinoma) [ Homo sapiens ]
• Official Symbol: ST14
• Synonyms: ST14; suppression of tumorigenicity 14 (colon carcinoma); PRSS14; suppressor of tumorigenicity 14 protein; epithin; HAI; matriptase; MT SP1; SNC19; TMPRSS14; prostamin; serine protease 14; serine protease TADG-15; membrane-type serine protease 1; tumor associated differentially expressed gene 15 protein; tumor-associated differentially-expressed gene 15 protein; suppression of tumorigenicity 14 (colon carcinoma, matriptase, epithin); MTSP1; MT-SP1; TADG15
• Gene ID: 6768
• mRNA Refseq: NM_021978
• Protein Refseq: NP_068813
• MIM: 606797
• UniProt ID: Q9Y5Y6
• Chromosome Location: 11q24-q25